RDHL
RDHL clinical trials: RedHill Biopharma Ltd.
Every trial on ClinicalTrials.gov where RedHill Biopharma Ltd. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 20
- Trials linked
- 19
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
RDHL on the catalyst calendar · RDHL registry changes
- Primary completion Jul 18, 2021ActualPhase 2/Phase 3NCT04467840Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 PneumoniaRedHill Biopharma Limited · COVID-19CompletedRDHLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 21, 2022ActualPhase 2NCT03377179A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced CholangiocarcinomaRedHill Biopharma Limited · CholangiocarcinomaCompletedRDHLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 28, 2023ActualPhase 3NCT04616924RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex DiseaseRedHill Biopharma Limited · Pulmonary Mycobacterium Avium Complex InfectionTerminatedRDHLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredNo phase registeredNCT03414489Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)RedHill Biopharma Limited · CholangiocarcinomaNo longer availableRDHLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 28, 2021ActualPhase 2/Phase 3NCT04723537Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 DiseaseRedHill Biopharma Limited · Covid19TerminatedRDHLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2025Sponsor estimatePhase 2NCT04027894Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 YearsRedHill Biopharma Limited · Traveler's DiarrheaUnknown statusRDHLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2025Sponsor estimatePhase 2NCT04026984Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 YearsRedHill Biopharma Limited · Traveler's DiarrheaUnknown statusRDHLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 26, 2020ActualPhase 2NCT04414618A Study of Opaganib in Coronavirus Disease 2019 PneumoniaRedHill Biopharma Limited · Coronavirus InfectionsCompletedRDHLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2019ActualPhase 1/Phase 2NCT02757326ABC294640 (Opaganib) in Refractory / Relapsed Multiple MyelomaRedHill Biopharma Limited · Multiple MyelomaTerminatedRDHLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 13, 2018ActualPhase 3NCT03009396Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's DiseaseRedHill Biopharma Limited · Crohn DiseaseCompletedRDHLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2018ActualPhase 3NCT01951326Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's DiseaseRedHill Biopharma Limited · Crohn's DiseaseCompletedRDHLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2021Sponsor estimatePhase 1/Phase 2NCT04502069Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring OxygenRedHill Biopharma Limited · COVID-19WithdrawnRDHLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 24, 2018ActualPhase 3NCT03198507ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active ComparatorRedHill Biopharma Limited · Helicobacter Pylori InfectionCompletedRDHLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2014ActualPhase 1NCT01488513ABC294640 in Treating Patients With Advanced Solid TumorsRedHill Biopharma Limited · Pancreatic CancerCompletedRDHLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2015ActualPhase 3NCT01980095ERADICATE Hp - Treating Helicobacter Pylori With RHB-105RedHill Biopharma Limited · DyspepsiaCompletedRDHLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 13, 2017ActualPhase 3NCT02246439BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or GastritisRedHill Biopharma Limited · GastroenteritisCompletedRDHLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 16, 2017ActualPhase 2NCT02757105Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea...RedHill Biopharma Limited · Irritable Bowel Syndrome With DiarrheaCompletedRDHLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2019Sponsor estimatePhase 1/Phase 2NCT02229981Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi SarcomaRedHill Biopharma Limited · Diffuse Large B Cell LymphomaWithdrawnRDHLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2015ActualPhase 2NCT01717664Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS)RedHill Biopharma Limited · Relapsing Remitting Multiple SclerosisCompletedRDHLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 24, 2025ActualPhase 2NCT05954286PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19Henry M. Jackson Foundation for the Advancement of Military Medicine · SARS-CoV-2CompletedRDHLCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 20 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner